Author | Young Tae Park, MD


Oral UFT and Leucovorin in Patients With Advanced Gastric Carcinoma

September 02, 1997

ByYeul Hong Kim, MD|Sang Won Shin, MD|Byung Soo Kim, MD|Young Tae Park, MD|Jongguk Kim, MD|Jun Suk Kim, MD

Thirty-nine patients with locally advanced or metastatic gastric carcinoma received oral UFT (tegafur and uracil) plus leucovorin. Treatment consisted of UFT 360 mg/m2/day plus leucovorin 25 mg/m2/day, given orally in divided